Goodwin Represents Underwriters for Taysha Gene Therapies $75M Public Offering
July 09, 2024
July 09, 2024
BOSTON, Massachusetts, July 9 -- Goodwin, a law firm, issued the following news release:
The Capital Markets team advised joint book-running managers Jefferies LLC and Goldman Sachs & Co. LLC, and book-running manager, Cantor Fitzgerald & Co., for Taysha Gene Therapies' (Nasdaq: TSHA) underwritten public offering of 14,361,113 shares of its common stock at a public offering price of $2.25 per share and in lieu of common stock to certain investors, pre-funded warrants to . . .
The Capital Markets team advised joint book-running managers Jefferies LLC and Goldman Sachs & Co. LLC, and book-running manager, Cantor Fitzgerald & Co., for Taysha Gene Therapies' (Nasdaq: TSHA) underwritten public offering of 14,361,113 shares of its common stock at a public offering price of $2.25 per share and in lieu of common stock to certain investors, pre-funded warrants to . . .